Form 4: Phreesia Inc. SVP, Life Sciences, David Linetsky, Reports Stock Sale to Cover Tax Obligations
SEC Form 4 Filing
David Linetsky, SVP of Life Sciences at Phreesia Inc., sold shares of common stock to cover tax withholding obligations related to the settlement of restricted stock units.
Summary
- On June 21, 2024, David Linetsky, SVP of Life Sciences at Phreesia Inc., disposed of 27 shares of common stock at a price of $20.2365 per share.
- The sale was executed to cover tax withholding obligations related to the settlement of restricted stock units, as per the issuer's mandatory sell-to-cover policy.
- Following the transaction, Linetsky directly owns 204,038 shares of Phreesia Inc. common stock and indirectly owns 6,953 shares through his spouse.
Sentiment
Score: 5
Explanation: Neutral sentiment as the transaction is a routine sale to cover tax obligations and doesn't indicate a change in the executive's outlook on the company.
Industry Context
This is a routine transaction related to executive compensation and tax obligations. It doesn't necessarily reflect a change in the executive's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 06/21/2024 | Date of stock sale transaction |
| 06/24/2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.